---
title: "BioLife Solutions climbs 8% on $1.5B Repligen acquisition deal"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293509865.md"
description: "BLFS rises 8% to $31.40 as Repligen agrees to buy it for $31 per share in cash and stock."
datetime: "2026-07-22T18:51:45.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293509865.md)
  - [en](https://longbridge.com/en/news/293509865.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293509865.md)
---

# BioLife Solutions climbs 8% on $1.5B Repligen acquisition deal

BioLife Solutions(BLFS.US) 盘中涨**7.57%**，现报**31.40**美元。

Repligen 宣布将以约**15**亿美元收购 BioLife Solutions，交易价格为每股**31**美元现金加股票组合。有律师事务所已发起调查，质疑该收购价格对公众股东是否公平。分析师目前给予该股「持有」评级共识，平均目标价为**33**美元。

### Related Stocks

- [BLFS.US](https://longbridge.com/en/quote/BLFS.US.md)

## Related News & Research

- [BioLife Solutions, Inc. (NASDAQ:BLFS) Receives Consensus Recommendation of "Hold" from Analysts](https://longbridge.com/en/news/293498720.md)
- [BioLife Solutions (NASDAQ:BLFS) Upgraded by Zacks Research to Strong-Buy Rating](https://longbridge.com/en/news/294339685.md)
- [Is Repligen (RGEN) Still Undervalued Following Its $1.5b BioLife Deal?](https://longbridge.com/en/news/293625486.md)
- [Are NG, BLFS, NRIM Obtaining Fair Deals for their Shareholders?](https://longbridge.com/en/news/294083853.md)
- [U.S. RESEARCH ROUNDUP- BioLife Solutions, Gossamer Bio, Intuit](https://longbridge.com/en/news/294026273.md)